Hrt Financial LP Ardelyx, Inc. Transaction History

Hrt Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$6.05 - $9.74 $807,717 - $1.3 Million	133,507 New	133,507 $974,000
Q3 2023 Nov 13, 2023	BUY	$3.3 - $4.83 $1.26 Million - $1.85 Million	382,899 New	382,899 $1.56 Million
Q1 2023 May 12, 2023	SELL	$2.68 - $4.79 $199,526 - $356,615	-74,450 Reduced 11.06%	598,634 $2.87 Million
Q4 2022 Feb 10, 2023	BUY	$1.22 - $2.85 $821,162 - $1.92 Million	673,084 New	673,084 $1.92 Million
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $107,325 - $212,154	-124,797 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $158,492 - $1.02 Million	124,797 New	124,797 $164,000
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $64,049 - $80,745	-10,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $53,025 - $74,550	10,500 New	10,500 $67,000
Q1 2019 May 14, 2019	SELL	$1.88 - $3.35 $30,982 - $55,208	-16,480 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.66 - $4.16 $27,356 - $68,556	16,480 New	16,480 $29,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.